ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
42 announcements
Kronox Lab Sciences Ltd reported revenue from operations of ₹28.4 Cr (+16.9% YoY) and net profit of ₹7.3 Cr (+15.9% YoY) for Q1 FY27.
Kronox Lab Sciences Limited will hold a board meeting on August 12, 2026. The board will consider and approve standalone financial results for the June quarter.
Kronox Lab Sciences clarified that recent share volume increases are market-driven. The company confirmed compliance with all material disclosure requirements under SEBI regulations.
Kronox Lab Sciences recommended a final dividend of ₹0.5 per share for FY 2025-26. Record and meeting dates will be finalized in a future meeting.
Kronox Lab Sciences reported annual revenue of ₹101.22 Crore and recommended a ₹0.50 per share final dividend. Results show stable performance for fiscal year 2026.
Kronox Lab Sciences Ltd reported revenue from operations of ₹26.1 Cr (+0.0% YoY) and net profit of ₹8 Cr (+27.0% YoY) for Q4 FY26.
Kronox Lab Sciences reported a total annual income of ₹106.41 Crore and recommended a 5% dividend. The firm maintains consistent profitability for shareholders.
Kronox Lab Sciences scheduled a board meeting on May 21, 2026. Directors will consider FY26 audited financial results and potential dividend recommendations for shareholders.
Kronox Lab Sciences rescheduled its board meeting to May 21, 2026. The board will consider audited annual financial results and a final dividend recommendation.
Kronox Lab Sciences Ltd clarified that recent share price movements are purely market-driven. The company confirmed it has disclosed all material information under SEBI regulations and is unaware of any specific reason for the price fluctuation.
Kronox Lab Sciences Ltd reported net profit of ₹6.6 Cr (+1.5% YoY) for Q3 FY26.
Kronox Lab Sciences Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The filing, received from Kfin Technologies Limited, confirms compliance regarding the dematerialization of securities. This is a routine regulatory disclosure with no immediate material financial impact.